The sales are pre-planned and immaterial in size. No bearish signal; monitor for any unplanned insider selling or changes to 10b5-1 plans.
INCY drugs
INCY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $122.27entry
- T+1 · 5d ago −0.47%α −0.11% · $121.70
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
CMO Steven Stein sold $4.07M in open-market shares under a 10b5-1 plan, and Principal Accounting Officer Thomas sold $73K, totaling $4.14M. The sales follow Incyte's Q3 earnings beat and raised guidance, but the dollar amount is only ~0.017% of market cap, making it routine insider selling.
Key Financial Metrics
Key Facts
- CMO Stein sold 35,000 shares at $116.06 for $4.07M under a 10b5-1 plan
- Principal Accounting Officer Thomas sold 610 shares at $118.96 for $73K under a 10b5-1 plan
- Total open-market sales: $4.14M, representing ~0.017% of Incyte's $24.4B market cap
- Sales occurred 8 days after Q3 earnings (Oct 29) which showed 14% revenue growth and raised guidance
- All sales were under 10b5-1 plans, indicating pre-planned transactions
Financial Impact
Total insider sales of $4.14M, negligible relative to $24.4B market cap
Risk Factors
- Insider selling is routine and immaterial; no elevated risk
- 10b5-1 plans reduce informational content of sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INCY-1794344905591 |
Track record
18 reports on INCY
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +23.70% at T+60 after the Jun 8, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $118.50 Now $120.27 +1.49% settles Feb 16
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $123.09 Now $120.27 −2.29% settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $119.45 Now $120.27 +0.69% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $120.97 Now $120.27 −0.58% settles Feb 11
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Viewing Entry $122.27 Now $120.27 −1.64% settles Feb 9
- Nov 6, 202610d ago 144 Neutral 4/10 Entry $121.89 Now $120.27 −1.33% settles Feb 5
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $122.85 Now $120.27 −2.10% settles Feb 2
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $116.80 Now $120.27 +2.97% settles Jan 27
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $115.71 Now $120.27 +3.94% settles Jan 21
- Aug 14, 202613w ago Insider Cluster Bearish 4/10 Entry $123.50 to $120.30 Now $120.27 +2.62% ▲ +2.59% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers